BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Țiburcă L, Bembea M, Zaha DC, Jurca AD, Vesa CM, Rațiu IA, Jurca CM. The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases. CIMB 2022;44:1851-66. [DOI: 10.3390/cimb44050127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shalaby M, Abdеlaziz RR, Ghoneim HA, Suddеk GM. Imatinib mitigates experimentally-induced ulcerative colitis: Possible contribution of NF-kB/JAK2/STAT3/COX2 signaling pathway. Life Sci 2023;:121596. [PMID: 36940909 DOI: 10.1016/j.lfs.2023.121596] [Reference Citation Analysis]
2 Harrison SR, Marzo-Ortega H. Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis? Curr Rheumatol Rep 2023;25:56-67. [PMID: 36652160 DOI: 10.1007/s11926-023-01097-7] [Reference Citation Analysis]
3 Xi L, Garcet S, Ye Z, Hung K, Hassan-Zahraee M, Kieras E, Krueger JG, Hyde C, Peeva E. A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis. Sci Rep 2022;12:19740. [PMID: 36396672 DOI: 10.1038/s41598-022-22465-w] [Reference Citation Analysis]
4 Hales D, Muntean DM, Neag MA, Kiss B, Ștefan MG, Tefas LR, Tomuță I, Sesărman A, Rațiu IA, Porfire A. Curcumin-Loaded Microspheres Are Effective in Preventing Oxidative Stress and Intestinal Inflammatory Abnormalities in Experimental Ulcerative Colitis in Rats. Molecules 2022;27:5680. [PMID: 36080447 DOI: 10.3390/molecules27175680] [Reference Citation Analysis]